Case Studies & Publications
Transforming Clinical Research. Advancing Healthcare.
TriNetX is dedicated to bridging the gap between clinical research and patient care through our cutting-edge data platform. Our case studies and publications reflect our commitment to providing actionable insights, fostering collaboration, and driving innovation in healthcare research.
Want to learn more about how TriNetX can support your research initiatives? Contact us for more information or schedule a demo to see our platform in action.
See TriNetX Case Studies
See TriNetX Scientific Publications
See TriNetX Publication Guidelines
See TriNetX Data Privacy Attestation
TriNetX Case Studies
Dive into our collection of case studies highlighting how TriNetX is making a tangible difference in healthcare. Our case studies offer a detailed look at how organizations are leveraging our platform to drive impactful research, streamline clinical trials, and accelerate the journey from data to discovery.
FEATURED CASE STUDY
East Lancashire Hospitals NHS Trust Leverages TriNetX to Automate Research Capabilities and Optimize Clinical Trial Patient Recruitment
CASE STUDY
Rapid Response and Deep Dive: University of New Mexico’s Clinical & Translational Science Center Simplifies Analytics and Accelerates Time to Insight with TriNetX Platform
CASE STUDY
Medical College of Wisconsin Leverages the TriNetX Platform to Win Grant Funding to Study Outcomes and Risk Factors for Sickle Cell Disease Patients with COVID-19
CASE STUDY
University of Oxford, U.K. Uses TriNetX Platform to Conduct Research on Mental Health Impact of COVID-19
CASE STUDY
TriNetX Helps Cuyahoga County’s MetroHealth System in Ohio Strive for Clinical Research Leadership Through Data Sharing
CASE STUDY
Expanding and Accelerating Research at the University of Texas Medical Branch (UTMB) Blocker Burn Unit with TriNetX
CASE STUDY
Enhancing Research Studies, Increasing Clinical Trial Opportunities at West Virginia Clinical and Translational Science Institute
CASE STUDY
Penn State Increases Access to Data, Enhances Research Efforts by Joining TriNetX Research Network
Recent TriNetX Scientific Publications
Stay informed with the latest research and findings published by our partners and team members. Our publications section features peer-reviewed articles, white papers, and reports that demonstrate the impact of TriNetX’s technology in the field of clinical research.
Capture of Long COVID in TriNetX: A Descriptive Analysis
Sentinel Modular Program Report. FDA Sentinal Initiative. (2024). https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/capture-long-covid-trinetx-descriptive-analysis
Comparing five equations to estimate glomerular filtration rate or creatinine clearance and assign individuals to KDIGO categories across the full age spectrum using real world data
, , , et al. Clin Transl Sci. 2024; 17:e13726. DOI: 10.1111/cts.13726
A pancreatic cancer risk prediction model (Prism) developed and validated on large-scale US clinical data
Jia K, Kundrot S, Palchuk MB, et al. eBioMedicine, vol. 98, Dec. 2023, p.104888. DOI: 10.1016/j.ebiom.2023.104888
TriNetX Colorectal Research Publications
Did the uptake of new treatment options change the treatment strategy in patients with colorectal cancer and primary non-resectable metastases?
The results of large population-based survey in Germany 2005-2007
TriNetX Esophagogastric Research Publications
Trastuzumab in Esophagogastric Cancer
HER2-Testing and Treatment Reality outside Clinical Studies in Germany
TriNetX Gastric Research Publications
TriNetX Lung Research Publications
TriNetX Lymphoma/Leukemia Research Publications
Behandlung indolenter Lymphome in Deutschland
Ergebnisse einer repräsentativen nationalen Erhebung
Indolente Non Hodgkin Lymphome
Trends in der Diagnose und in der Therapie in Deutschland (2006-2009)
TriNetX MDS Research Publications
TriNetX Multiple Myeloma Research Publications
Treatment Situation for Newly Diagnosed Multiple Myeloma Patients in Germany
First Results from a Representative Multicentre Treatment Survey
Role of Bortezomib in the Treatment of Multiple Myeloma
First Results from a Representative Multicentre Treatment Survey in Germany
Anwendung neuer Therapien zur Behandlung des multiplen Myeloms
Ergebnisse einer repräsentativen multizentrischen Erhebung 2006
Treatment of multiple myeloma in Germany
An update of a representative multicentre health care survey 2004‐2011
Diagnostic and therapeutic approaches to multiple myeloma patients
‘Real-world’ data from representative multicentre treatment surveys in Germany between 2008 and 2011
Diagnosis and treatment of multiple myeloma in Germany
Analysis of a nationwide, multi-institutional survey
Evolving Treatment Trends in Relapsed/Refractory Multiple Myeloma in Europe from 2016 to 2018
Analysis of a Multi-National Survey
Comparative Effectiveness of Pomalidomide Plus Low-Dose Dexamethasone (POM+LoDEX) in Relapsed and Refractory Multiple Myeloma
Use of Real-World Data in the Absence of Head-to-Head Studies
TriNetX Oncology GmbH is a wholly owned subsidiary of TriNetX, LLC.
TriNetX Contact Information for Physicians in Europe:
Tel: +49 761 – 38 39 94 – 0 | Fax: +49 761 – 20 25 117 | oncology@trinetx.com